Literature DB >> 14512739

1H, 13C and 15N resonance assignments and secondary structure of the human protein tyrosine phosphatase, PRL-2.

Hongjun Zhou, Marijo Gallina, Hongyuan Mao, Daniel Nietlispach, Stephen F Betz, Jacquelyn S Fetrow, Peter J Domaille.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14512739     DOI： 10.1023/a:1025875618084

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN： 0925-2738            Impact factor:   2.835


× No keyword cloud information.
  9 in total

Review 1.  Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cells.

Authors:  F Tamanoi; C L Gau; C Jiang; H Edamatsu; J Kato-Stankiewicz
Journal:  Cell Mol Life Sci       Date:  2001-10       Impact factor: 9.261

2.  PRL-1 PTPase expression is developmentally regulated with tissue-specific patterns in epithelial tissues.

Authors:  W Kong; G P Swain; S Li; R H Diamond
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-09       Impact factor: 4.052

3.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology.

Authors:  G Cornilescu; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  1999-03       Impact factor: 2.835

4.  A phosphatase associated with metastasis of colorectal cancer.

Authors:  S Saha; A Bardelli; P Buckhaults; V E Velculescu; C Rago; B St Croix; K E Romans; M A Choti; C Lengauer; K W Kinzler; B Vogelstein
Journal:  Science       Date:  2001-10-11       Impact factor: 47.728

5.  Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene.

Authors:  Qin Wang; David I R Holmes; Sue M Powell; Qi L Lu; Jonathan Waxman
Journal:  Cancer Lett       Date:  2002-01-10       Impact factor: 8.679

6.  Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1.

Authors:  Q Zeng; W Hong; Y H Tan
Journal:  Biochem Biophys Res Commun       Date:  1998-03-17       Impact factor: 3.575

7.  PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth.

Authors:  R H Diamond; D E Cressman; T M Laz; C S Abrams; R Taub
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

8.  Pentamidine is an inhibitor of PRL phosphatases with anticancer activity.

Authors:  Manas K Pathak; Deepika Dhawan; Daniel J Lindner; Ernest C Borden; Carol Farver; Taolin Yi
Journal:  Mol Cancer Ther       Date:  2002-12       Impact factor: 6.261

9.  The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data.

Authors:  D S Wishart; B D Sykes
Journal:  J Biomol NMR       Date:  1994-03       Impact factor: 2.835
  9 in total
  4 in total

1.  1H, 15N, 13C resonance assignments of the reduced and active form of human Protein Tyrosine Phosphatase, PRL-1.

Authors:  Andria L Skinner; Jennifer S Laurence
Journal:  Biomol NMR Assign       Date:  2009-01-08       Impact factor: 0.746

2.  Elevated PRL-3 expression was more frequently detected in the large primary gastric cancer and exhibits a poor prognostic impact on the patients.

Authors:  Zhao Wang; Shi-Rong Cai; Yu-Long He; Wen-Hua Zhan; Chang-Hua Zhang; Hui Wu; Jian-Jun Peng; Jian-Bo Xu; Xin-Hua Zhang; Liang Wang; Wu Song
Journal:  J Cancer Res Clin Oncol       Date:  2009-01-09       Impact factor: 4.553

3.  1H, 15N, 13C resonance assignments of the human protein tyrosine phosphatase PRL-1.

Authors:  Jennifer S Laurence; Klaas Hallenga; Cynthia V Stauffacher
Journal:  J Biomol NMR       Date:  2004-07       Impact factor: 2.835

4.  A retrospective cohort study of clinical value of PRL-3 in stage III human colorectal cancer.

Authors:  Chuanyuan Liu; Wu Zhong; Laiyang Xia; Chuanfa Fang; Hongquan Liu; Xiaochun Liu
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.